— Item 3 of 10 mY wax <q Se i @ al Lo) id @A &s

— " . uL ~
Question Id: 19309 Previous Next Full Screen Tutorial Lab Values Notes Calculator Reverse Color Text Zoom Settings

Researchers conducted a randomized controlled trial to assess the effectiveness of a new
drug to reduce severe cutaneous reactions in patients with rheumatoid arthritis who are treated
with adalimumab. Of 150 adults with rheumatoid arthritis who are treated with adalimumab, 75
received the new drug in addition to adalimumab, and 75 received a placebo in addition to

_
Th

adalimumab. Results show that 6 patients in the new drug group developed severe cutaneous
reactions, compared to 9 in the placebo group. Which of the following represents the relative
risk reduction for severe cutaneous reactions among patients in the new drug group?

© A. 0.08
© B. 0.10
© C.0.12
© D.0.33
© E. 0.67

Activate Windows

Block Time Elapse

Tutor Feedback id = End Block
